GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Notable Labs Ltd (NAS:NTBL) » Definitions » PensionAndRetirementBenefit

Notable Labs (Notable Labs) PensionAndRetirementBenefit : $0.00 Mil (As of Dec. 2023)


View and export this data going back to 2023. Start your Free Trial

What is Notable Labs PensionAndRetirementBenefit?

Notable Labs's PensionAndRetirementBenefit for the quarter that ended in Dec. 2023 was $0.00 Mil.


Notable Labs PensionAndRetirementBenefit Historical Data

The historical data trend for Notable Labs's PensionAndRetirementBenefit can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Notable Labs PensionAndRetirementBenefit Chart

Notable Labs Annual Data
Trend Dec21 Dec22 Dec23
PensionAndRetirementBenefit
- - -

Notable Labs Semi-Annual Data
Dec21 Dec22 Dec23
PensionAndRetirementBenefit - - -

Notable Labs PensionAndRetirementBenefit Calculation

PensionAndRetirementBenefit is the carrying amount as of the balance sheet date of the portion of the obligations recognized for the various benefits provided to former or inactive employees, their beneficiaries, and covered dependents after employment but before retirement.


Notable Labs (Notable Labs) Business Description

Traded in Other Exchanges
N/A
Address
320 Hatch Drive, Foster City, CA, USA, 94404
Notable Labs Ltd is a clinical-stage platform therapeutics company developing predictive precision medicines for patients with cancer. Through its proprietary Predictive Precision Medicines Platform (PPMP), Notable bio-simulates a cancer treatment to predict whether or not a patient is likely to respond to that specific therapeutic. Through its proprietary Predictive Precision Medicines Platform (PPMP), Notable bio-simulates a cancer treatment to predict whether or not a patient is likely to respond to that specific therapeutic.